Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru
This study on cbd powder formulation pharmacokinetics reveals comparable bioavailability to traditional oil-based CBD products. It highlights formulation-dependent food effects on absorption in healthy adults. While bioequivalence is established,…
The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial.
This CBD sleep disturbances trial investigates cannabidiol's effects on sleep in individuals with high trait worry. The study is a double-blind, randomized placebo controlled trial. It provides important insights into CBD's role in managing sleep…
CBD for Brain Tumor Anxiety: What This Trial Found
Advanced cannabis clinical evidence shows that CBD for brain tumor anxiety did not outperform placebo in reducing anxiety or depressive symptoms. This early-terminated randomized trial enrolled adults with primary brain tumors and clinically relevant…
CBD Guangzhou 2026 to Showcase Building Decoration and Smart Home Innovations
The 2026 global building decoration innovations event in Guangzhou's CBD highlights emerging trends in smart home technology. This trade show showcases advancements in building decoration and smart solutions. The focus on 2026 global building decoration…
Cannabidiol and Diabetic Heart Disease: Mechanistic Evidence and Translational Challenges
CBD diabetic heart disease preclinical research evidence reveals promising cardioprotective mechanisms including oxidative stress reduction and anti-inflammatory effects. These findings provide a scientific foundation for future clinical studies.…
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav
Jazz Pharmaceuticals is advancing pharmaceutical grade CBD research with new findings on Epidiolex and Xywav. This research helps establish evidence-based dosing protocols and safety profiles. Such data is critical for broader cannabinoid medicine…
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav … – Investors
Jazz Pharmaceuticals continues pharmaceutical CBD research with new presentations on Epidiolex. These studies focus on expanding evidence-based cannabinoid medicine beyond approved epilepsy indications. Pharmaceutical CBD research informs off-label…
FDA Grants Limited Enforcement Discretion for CBD in Dietary Supplements
FDA enforcement discretion CBD policy marks a new regulated pathway for dietary supplements in the U.S. This shift may improve product quality oversight and patient access. Clinicians should understand these changes to guide patient care effectively.
Impact of CBD and Hemp Oil Use on Drug Test Results: A Systematic Review
Drug testing CBD hemp products is a common concern for patients considering CBD therapy. This systematic review provides evidence-based guidance on drug test risks associated with CBD and hemp oil use. Understanding these risks helps clinicians counsel…
Moving Crest LLC Cannabidiol Capsules: Beyond Stress and Pain Benefits
Commercial CBD products health claims require careful clinical scrutiny. This article reviews cannabidiol capsules and their potential benefits beyond stress and pain. Understanding the evidence gap helps clinicians guide patients effectively.